The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Is there any survival benefit of additional chemotherapy (C) following adjuvant C in pancreatic cancer (PC) patients (pts) with postsurgery elevated CA19-9?

Wasif M.  Saif

Consulting or Advisory Role - EMD Serono

Speakers' Bureau - Amgen; Celgene; Genentech; Ipsen; Novartis; Sirtex Medical

Research Funding - Celgene (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); NanoCarrier; Pharmacyclics; Taiho Pharmaceutical (Inst)

Melissa H  Smith

Speakers' Bureau - Guardant Health; Ipsen; Taiho Pharmaceutical

Martin D.  Goodman

No Relationships to Disclose

Suzanne M.  Russo

No Relationships to Disclose

Kathryn  Huber

No Relationships to Disclose

Ronald R  Salem

No Relationships to Disclose